Lv32
304 积分 2024-11-13 加入
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
17天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
18天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
28天前
已完结
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
29天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
29天前
已完结
Associations between Class I, II, or III Obesity and Health Outcomes
1个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
1个月前
已完结
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics
1个月前
已完结
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
1个月前
已完结
皖公网安备34019202002308
